We are live on ! Find out more
WAM

Westport Asset Management Portfolio holdings

AUM $226M
1-Year Est. Return 16.76%
This Fund
S&P 500
This Quarter Est. Return
-1.3%
1 Year Est. Return
+16.76%
3 Year Est. Return
+61.43%
5 Year Est. Return
+63.79%
10 Year Est. Return
AUM
$209M
AUM Growth
-$4.34M
Cap. Flow
+$1.11M
Cap. Flow %
0.53%
Top 10 Hldgs %
56.38%
Holding
76
New
2
Increased
1
Reduced
1
Closed
2

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$242K
2
ROG icon
Rogers Corp
ROG
+$125K
3
WFC icon
Wells Fargo
WFC
+$56.5K

Sector Composition

Rank Sector Weight
1 Technology 37.78%
2 Financials 18.52%
3 Industrials 9.23%
4 Healthcare 8.42%
5 Consumer Discretionary 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKAM icon
26
Akamai
AKAM
$15.9B
$2.39M 1.14%
25,000
IBM icon
27
IBM
IBM
$224B
$2.2M 1.05%
10,000
ROG icon
28
Rogers Corp
ROG
$2.4B
$2.08M 0.99%
20,456
-1,200
-6% -$125K
CACI icon
29
CACI
CACI
$14.2B
$2.02M 0.97%
5,000
UNP icon
30
Union Pacific
UNP
$174B
$2.01M 0.96%
8,800
EXP icon
31
Eagle Materials
EXP
$6.57B
$1.97M 0.94%
8,000
AMZN icon
32
Amazon
AMZN
$2.96T
$1.91M 0.92%
8,720
NSC icon
33
Norfolk Southern
NSC
$75.1B
$1.41M 0.67%
6,000
TXN icon
34
Texas Instruments
TXN
$261B
$1.13M 0.54%
6,026
WBD icon
35
Warner Bros
WBD
$67.1B
$1.01M 0.48%
95,800
SKX
36
DELISTED
Skechers
SKX
$1.01M 0.48%
15,000
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$126B
$1.01M 0.48%
+2,500
New +$1.16M
BIO icon
38
Bio-Rad Laboratories Class A
BIO
$9.42B
$986K 0.47%
3,000
AZN icon
39
AstraZeneca
AZN
$250B
$983K 0.47%
7,500
GILD icon
40
Gilead Sciences
GILD
$165B
$924K 0.44%
10,000
CVS icon
41
CVS Health
CVS
$122B
$798K 0.38%
17,772
LITE icon
42
Lumentum
LITE
$69.3B
$798K 0.38%
9,500
FMC icon
43
FMC
FMC
$1.33B
$729K 0.35%
15,000
T icon
44
AT&T
T
$163B
$727K 0.35%
31,919
APD icon
45
Air Products & Chemicals
APD
$67.6B
$725K 0.35%
2,500
ANSS
46
DELISTED
Ansys
ANSS
$675K 0.32%
2,000
MDU icon
47
MDU Resources
MDU
$4.32B
$631K 0.3%
35,000
+7,925
+29% +$139K
VRNT
48
DELISTED
Verint Systems
VRNT
$618K 0.3%
22,500
FCPT icon
49
Four Corners Property Trust
FCPT
$2.75B
$543K 0.26%
19,998
NTR icon
50
Nutrien
NTR
$30.7B
$499K 0.24%
11,150

Similar funds

Westport Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Westport Asset Management held 76 positions worth $209M, down 2% from $213M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Westport Asset Management's Q4 2024 filing shows 2 new, 1 increased, 1 reduced and 2 closed positions. Its largest new stake was Vertex Pharmaceuticals: 2,500 shares worth $1.01M. The largest sale was CATALENT, INC., an estimated $242K.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 38% a quarter earlier, followed by Financials and Industrials.

  • Westport Asset Management's largest Q4 2024 buy was Vertex Pharmaceuticals: 2,500 shares worth $1.01M.
  • Westport Asset Management added most to MDU Resources in Q4 2024, an estimated $139K increase.
  • Westport Asset Management's biggest Q4 2024 reduction was Rogers Corp, cutting an estimated $125K.
  • Westport Asset Management fully exited CATALENT, INC. in Q4 2024, selling an estimated $242K.
  • Westport Asset Management's ten largest holdings make up 56% of its $209M portfolio in Q4 2024.
  • Westport Asset Management opened 2 new positions and closed 2 in Q4 2024.
  • Westport Asset Management's portfolio value fell 2% quarter-over-quarter to $209M.

Based on Westport Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.